RYAM’s 2025 Close: A Cash-First Tune-Up as It Recasts the Cellulose Lineup

RYAM (ticker: RYAM) reported its Fourth Quarter 2025 results with an EPS of $(0.32) per diluted share and net sales of $417 million for the quarter. The release notes a year of broad headwinds and a strategic pivot toward cash generation, with full-year revenue of about $1.5 billion, Adjusted EBITDA of $133 million, and negative Adjusted Free Cash Flow of $88 million. Management frames 2026 as a disciplined push toward positive free cash flow, even as volumes and working capital work to the opposite tune. There isn’t an explicit EPS consensus or revenue forecast in the document, leaving investors to weigh this quarter against broader sector dynamics and the company’s own pivot plan.

Earnings Snapshot

The company reported a quarterly loss from continuing operations and a net loss of $21 million, or $(0.32) per diluted share, for the quarter ended December 31, 2025. The same figure for the prior-year quarter was a loss of $0.25 per diluted share. Net sales for the quarter were $417 million, down modestly versus the prior year. These numbers sit in a year of mixed signals: a single-quarter result that resembles a typical cyclical materials story—low leverage on the operating line but weak free cash flow masking the EBITDA backdrop.

Full-Year Context and Operating Pulse

For the year, Rayonier Advanced Materials reported revenue of about $1.5 billion, Adjusted EBITDA of $133 million, and negative Adjusted Free Cash Flow of $88 million. These lines illustrate a constraint on the cash conversion of earnings, despite a relatively sizable top line. The company also disclosed a total debt burden of $779 million and net secured debt of $715 million, with a covenant net secured leverage ratio of 3.9x, signaling a watchful capital structure that prioritizes covenant compliance and liquidity management.

Strategic Restructuring and What It Means

In January 2025, the company restructured its former High Purity Cellulose segment into three businesses: Cellulose Specialties, Biomaterials, and Cellulose Commodities. No changes were made to the Paperboard and High-Yield Pulp segments. The prior period results were recast to align with this new structure, signaling management’s intent to sharpen focus on higher-value niches while clearly separating underperforming or less-cash-generative lines. The narrative emphasizes a path from EBITDA improvement toward actual cash generation, with leadership intent to tighten working capital and reduce capital expenditure relative to 2025—allocating spend to essential maintenance and the highest-return projects.

Management Commentary: A Plan with Cash at the Center

CEO Scott Sutton framed 2025 as a difficult year and laid out a 2026 plan anchored in disciplined execution and cash discipline. “In 2026, our focus is sharpening around disciplined execution and cash,” he said, outlining priorities to deliver positive free cash flow, strengthen leadership in Cellulose Specialties, and push year-over-year EBITDA improvements across all segments. He acknowledged near-term volume headwinds as customers adjust ordering and inventories, while signaling a deliberate tightening of fixed costs and CapEx. The emphasis is on converting EBITDA improvements into real cash, a transition many in the sector would welcome given the debt and liquidity backdrop.

Operational Metrics, Cash, and Levers to Watch

The quarterly and annual cash picture remains fragile: Cash Provided by Operating Activities for the year was about $24 million year-to-date, with negative Adjusted Free Cash Flow of $88 million. The balance sheet carries a substantial debt stack, and covenant leverage remains a point of focus for lenders. Management’s plan to prioritize cash generation, reduce non-critical capital outlays, and direct capital toward maintenance and higher-return projects is a notable shift for a company with a sizable manufacturing footprint that touches multiple cellulose segments. How quickly that translates into free cash flow will influence not only the equity story but debt capacity and potential refinancing options.

Implications for the Sector and Peers

The strategic pivot toward three-cellulose-segment focus mirrors a broader industry impulse: unpack the value chain to identify the cash return on specialized products. If RYAM can stabilize cash flow and begin to show positive free cash flow in 2026, peers with similar mix sensitivities—where pricing power and volumes hinge on demand in specialty cellulose—may find it prudent to accelerate similar restructurings or capital discipline. In the near term, investors will parse the company’s ability to translate EBITDA improvements into actual cash and whether the new segment philosophy yields data points that can guide peer reallocation of assets or pricing strategies. The absence of explicit revenue forecasts or consensus expectations makes the story a test of execution over guidance, a test many sector participants are running this year.

Bottom Line: A Cash-Oriented Read on 2026

RYAM’s fourth quarter underscores a company in transition: it has redefined its product portfolio, tightened its strategic foci, and is signaling a pivot toward cash generation despite a challenging macro backdrop. For EPS watchers, the near-term result is a reminder that a quarterly number can be a poor proxy for a strategic calibration. The absence of explicit EPS consensus or revenue forecast numbers invites a cautious stance, but the announced plan—sharpened focus on Cellulose Specialties, disciplined capex, and working-capital efficiency—provides a plausible path to restoring positive free cash flow if operating discipline holds and demand coalesces around higher-value segments.